{"title":"家血液透析。","authors":"Benno Kitsche, Dieter Bach","doi":"10.1007/s11560-021-00517-y","DOIUrl":null,"url":null,"abstract":"<p><p>Home hemodialysis (HHD) is the cornerstone of renal replacement therapy in Germany. From 1969, it enabled survival with a diagnosis that up to then had been fatal; however, with the development of a good network of dialysis centers, the knowledge and experience of HHD was increasingly lost. Today, HHD is practically no longer included in the education. Insufficient information and a lack of HHD services are the result. Currently, less than 0.8% of patients in Germany are treated with HHD. In the development of dialysis machines, the industry focused on stand-alone machines for the centers. This form of treatment hinders mobility and limits the activities of patients with renal insufficiency requiring dialysis. Starting with the Advancing American Kidney Health Initiative there has been a welcome momentum in the development of innovative, wearable and implantable artificial kidneys. This can improve the quality of life and reduce the mortality rate. The first initiatives have also emerged in Germany and Europe. These innovative devices and the associated transition in renal replacement therapy will solve many problems of the nephrology community, such as personnel shortages or the lack of donor organs and death on the waiting list and give patients independence and mobility. The cost burden on healthcare systems can be reduced. In addition, the immense water and electricity consumption will be dramatically reduced by the regenerative techniques of the new machines.</p>","PeriodicalId":41844,"journal":{"name":"Nephrologe","volume":"16 5","pages":"292-298"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11560-021-00517-y","citationCount":"3","resultStr":"{\"title\":\"[Home hemodialysis].\",\"authors\":\"Benno Kitsche, Dieter Bach\",\"doi\":\"10.1007/s11560-021-00517-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Home hemodialysis (HHD) is the cornerstone of renal replacement therapy in Germany. From 1969, it enabled survival with a diagnosis that up to then had been fatal; however, with the development of a good network of dialysis centers, the knowledge and experience of HHD was increasingly lost. Today, HHD is practically no longer included in the education. Insufficient information and a lack of HHD services are the result. Currently, less than 0.8% of patients in Germany are treated with HHD. In the development of dialysis machines, the industry focused on stand-alone machines for the centers. This form of treatment hinders mobility and limits the activities of patients with renal insufficiency requiring dialysis. Starting with the Advancing American Kidney Health Initiative there has been a welcome momentum in the development of innovative, wearable and implantable artificial kidneys. This can improve the quality of life and reduce the mortality rate. The first initiatives have also emerged in Germany and Europe. These innovative devices and the associated transition in renal replacement therapy will solve many problems of the nephrology community, such as personnel shortages or the lack of donor organs and death on the waiting list and give patients independence and mobility. The cost burden on healthcare systems can be reduced. In addition, the immense water and electricity consumption will be dramatically reduced by the regenerative techniques of the new machines.</p>\",\"PeriodicalId\":41844,\"journal\":{\"name\":\"Nephrologe\",\"volume\":\"16 5\",\"pages\":\"292-298\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s11560-021-00517-y\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nephrologe\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s11560-021-00517-y\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/8/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrologe","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s11560-021-00517-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/8/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Home hemodialysis (HHD) is the cornerstone of renal replacement therapy in Germany. From 1969, it enabled survival with a diagnosis that up to then had been fatal; however, with the development of a good network of dialysis centers, the knowledge and experience of HHD was increasingly lost. Today, HHD is practically no longer included in the education. Insufficient information and a lack of HHD services are the result. Currently, less than 0.8% of patients in Germany are treated with HHD. In the development of dialysis machines, the industry focused on stand-alone machines for the centers. This form of treatment hinders mobility and limits the activities of patients with renal insufficiency requiring dialysis. Starting with the Advancing American Kidney Health Initiative there has been a welcome momentum in the development of innovative, wearable and implantable artificial kidneys. This can improve the quality of life and reduce the mortality rate. The first initiatives have also emerged in Germany and Europe. These innovative devices and the associated transition in renal replacement therapy will solve many problems of the nephrology community, such as personnel shortages or the lack of donor organs and death on the waiting list and give patients independence and mobility. The cost burden on healthcare systems can be reduced. In addition, the immense water and electricity consumption will be dramatically reduced by the regenerative techniques of the new machines.
期刊介绍:
Zielsetzung der Zeitschrift
Der Nephrologe bietet aktuelle und kompakte Fortbildung für alle nephrologisch tätigen Ärzt*innen in Klinik und Praxis. Inhaltlich werden sämtliche Bereiche der angewandten Nephrologie und Hypertensiologie praxisnah abgedeckt. Das Spektrum reicht von der Prävention, diagnostischen Vorgehensweisen und Komplikationsmanagement bis hin zu modernen Therapiestrategien.
Umfassende Übersichtsarbeiten zu einem aktuellen Schwerpunktthema sind das Kernstück jeder Ausgabe. Im Mittelpunkt steht dabei gesichertes Wissen zu Diagnostik und Therapie mit hoher Relevanz für die tägliche Arbeit.
Beiträge der Rubrik "CME Zertifizierte Fortbildung" bieten gesicherte Ergebnisse wissenschaftlicher Forschung und machen ärztliche Erfahrung für die tägliche Praxis nutzbar. Nach Lektüre der Beiträge können die Leser*innen ihr erworbenes Wissen überprüfen und online CME-Punkte erwerben. Die Rubrik orientiert sich an der Weiterbildungsordnung des Fachgebiets.
Aims & Scope
Der Nephrologe offers up-to-date information for all nephrologists working in practical and clinical environments and scientists who are particularly interested in issues of nephrology.
The content covers all areas of applied nephrology and hypertensiology. The topics range from prevention to diagnostic approaches and management of complications to current therapy strategies.
Comprehensive reviews on a specific topical issue provide evidenced based information on diagnostics and therapy.
Review articles under the rubric ''Continuing Medical Education'' present verified results of scientific research and their integration into daily practice.
Review
All articles of Der Nephrologe are reviewed.
Declaration of Helsinki
All manuscripts submitted for publication presenting results from studies on probands or patients must comply with the Declaration of Helsinki.